Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0672-6
PubMed Identifier: 31894140
Publication URI: http://europepmc.org/abstract/MED/31894140
Type: Journal Article/Review
Volume: 122
Parent Publication: British journal of cancer
Issue: 6
ISSN: 0007-0920